BLINCYTO, created in 2013 (United States), from
142 sister brands
and 17477 competing brands.
BLINCYTO is owned by Amgen, listed on the stock exchange of New York
BLINCYTO belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.